Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Olfactory receptor family 1 subfamily D member 2 (OR1D2) is a G protein-coupled receptor that detects odorant molecules in the nose, initiating neuronal signaling that leads to the perception of smell[2][3]. It is part of the largest gene family in the genome and features a 7-transmembrane domain structure like other receptors for neurotransmitters and hormones[2][3]. In addition to its role in olfaction, OR1D2 is expressed in human spermatozoa, where it has been shown to mediate sperm chemotaxis, possibly in response to specific odorants such as bourgeonal[1][2]. OR1D2 is a broadly tuned receptor, capable of responding to a large variety of structurally diverse chemical compounds, without a clear pattern of agonist structure or organoleptic characteristics; many identified ligands are floral, fruity, or citrus in character[1]. There is currently no established therapeutic targeting, interacting drugs, or known biomarker or safety concerns for OR1D2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor family 1 subfamily D member 2 (OR1D2).